LOADING
Comparing AbbVie Inc (ABBV) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $368.4B | $171.3B |
| P/E Ratio | 102.2 | 8.1 |
| Forward P/E | 14.1 | 10.9 |
| PEG Ratio | 0.56 | 1.76 |
| EPS | $2.04 | $3.04 |
| Revenue Growth (YoY) | 12.4% | 2.9% |
| Profit Margin | 5.8% | 16.9% |
| Return on Equity | 62.3% | 18.4% |
| Dividend Yield | 3.24% | 4.49% |
| Beta | 0.30 | 0.42 |
| 52-Week High | $239.13 | $29.14 |
| 52-Week Low | $174.56 | $22.71 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AT&T Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.